These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 2396109)

  • 21. [Changes of red cell membrane lipids in diabetes mellitus as measured by Iatroscan (author's transl)].
    Kamada T; Baba Y; Otsuji S
    Rinsho Byori; 1980 Feb; 28(2):175-80. PubMed ID: 7366017
    [No Abstract]   [Full Text] [Related]  

  • 22. [Metabolic effects of gliclazide in diabetes type II patients. Study with indirect calorimetry].
    Golay A; Broquet C; Chabot V; Studer S; Felber JP
    Schweiz Med Wochenschr; 1984 Feb; 114(8):261-4. PubMed ID: 6369531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect of insulin on the lipid composition of the erythrocyte membranes of diabetics].
    Kozlov GS; Buĭdina TA; Pribytkov IuN
    Vrach Delo; 1990 Nov; (11):92-5. PubMed ID: 2098998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythrocyte deformability in diabetes and erythrocyte membrane lipid composition.
    Garnier M; Attali JR; Valensi P; Delatour-Hanss E; Gaudey F; Koutsouris D
    Metabolism; 1990 Aug; 39(8):794-8. PubMed ID: 2377077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid changes in red cell membrane in leukaemia.
    Suhail M; Athar J; Rizvi SI
    Indian J Med Res; 1988 Oct; 88():353-5. PubMed ID: 3225020
    [No Abstract]   [Full Text] [Related]  

  • 26. [Changes in red blood cell membrane properties during cardiopulmonary bypass for open-heart surgery].
    Tabata R; Mori A; Ueno Y; Matsuda M; Kato H; Okada Y
    Nihon Kyobu Geka Gakkai Zasshi; 1984 Aug; 32(8):1199-204. PubMed ID: 6512315
    [No Abstract]   [Full Text] [Related]  

  • 27. [How I treat... a non-obese patient with Type 2 diabetes].
    Scheen AJ
    Rev Med Liege; 1994 Mar; 49(3):121-2. PubMed ID: 8184217
    [No Abstract]   [Full Text] [Related]  

  • 28. Membrane phospholipid asymmetry and the adherence of loaded red blood cells.
    Schlegel RA; McEvoy L; Williamson P
    Bibl Haematol; 1985; (51):150-6. PubMed ID: 4004759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and characterization of fluorescent Lucifer yellow-lipid conjugates.
    Nothnagel EA
    Biochim Biophys Acta; 1989 Apr; 980(2):209-19. PubMed ID: 2930788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Use of plasmapheresis in the comprehensive therapy of patients with diabetes mellitus].
    Sokolov EI; Podachina SV; Zabornov VI; Zanina EB
    Probl Endokrinol (Mosk); 1994; 40(5):13-6. PubMed ID: 7899430
    [No Abstract]   [Full Text] [Related]  

  • 31. [Structuro-functional characteristics of biological membranes in mucoviscidosis in children].
    Reznik BIa
    Pediatriia; 1984 Oct; (10):22-5. PubMed ID: 6514458
    [No Abstract]   [Full Text] [Related]  

  • 32. [Biguanides in diabetes therapy. New aspects with special regard to the metabolic syndrome. Satellite symposium of the 2nd German Physicians' Conference. Dresden, 15 June 1991].
    Internist (Berl); 1991; 32(8 Suppl):1-12. PubMed ID: 1682287
    [No Abstract]   [Full Text] [Related]  

  • 33. Determination of membrane cholesterol in normal and pathological red blood cells.
    Macchia T; Mancinelli R; Barbini DA; Taggi F; Avico U; Cantafora A
    Clin Chim Acta; 1991 May; 199(1):59-67. PubMed ID: 1934503
    [No Abstract]   [Full Text] [Related]  

  • 34. Cholesterol content of erythrocyte membranes and elusive target.
    Pavlaki M; Kourkouli A; Chalikias G; Kikas P; Tziakas D
    Thromb Res; 2020 Jan; 185():32. PubMed ID: 31739200
    [No Abstract]   [Full Text] [Related]  

  • 35. [The effect of diabeton and metformin on the free-radical oxidation processes and the structural characteristics of the phospholipid composition of the erythrocyte membranes in non-insulin-dependent diabetes mellitus].
    Buĭdina TA; Kozlov GS; Balabolkin MI
    Sov Med; 1991; (7):14-6. PubMed ID: 1948331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Reclid effects on carbohydrate, lipid metabolism, lipid peroxidation and hemodynamics in patients with diabetes mellitus type 2].
    Shustov SB; Romashevskiĭ BV; Khalimov IuSh; Stepanova OIu; Lysenko AG
    Klin Med (Mosk); 2000; 78(11):45-8. PubMed ID: 11232532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial.
    Charbonnel BH; Matthews DR; Schernthaner G; Hanefeld M; Brunetti P;
    Diabet Med; 2005 Apr; 22(4):399-405. PubMed ID: 15787663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Compositional alterations of erythrocyte membrane lipid and red cell deformability in diabetes].
    Qiu H
    Zhonghua Yi Xue Za Zhi; 1991 Jan; 71(1):21-3. PubMed ID: 1850649
    [No Abstract]   [Full Text] [Related]  

  • 39. [Spectrum of erythrocyte membrane lipids in various types of hypoglycemic therapy].
    Kozlov GS; Buĭdina TA; Balabolkin MI
    Sov Med; 1990; (6):10-3. PubMed ID: 2396109
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.